Pfizer Türkiye has been recognized as the 2nd “Most Admired Company” in the pharmaceutical sector in Capital Magazine’s 26th annual survey. Conducted between August and November 2025 with 1,500 executives across 62 sectors, the study evaluated companies on 20 criteria, including service quality and financial strength. This year’s recognition is particularly significant as it highlights Pfizer’s excellence in “Value Given to Employees” and “Reliability,” reflecting the company’s science-and-people-first mission and the trust it inspires among business professionals.
